Michael Limmert

Michael Limmert currently serves as the Head of Chemical Development at Arevipharma GmbH, where he plays a pivotal role in advancing the company's portfolio of Active Pharmaceutical Ingredients (APIs). In this leadership position, Michael oversees a dynamic team of highly skilled chemists and lab assistants, guiding them through complex process development projects that are critical to the company's growth and innovation. His expertise in organic chemistry, combined with his extensive experience in GMP compliance and cGMP standards, ensures that all development activities meet stringent regulatory requirements, facilitating smooth process transfers and validation procedures.

A key focus of Michael’s role involves exploring new business opportunities by identifying and implementing innovative techniques in chemical synthesis and process optimization. His proficiency in Design of Experiments (DoE) and catalysis allows him to streamline development workflows, reduce time-to-market, and improve process robustness. Additionally, Michael actively shapes Arevipharma’s product and intellectual property (IP) portfolio by assessing feasibility studies, conducting FTO (Freedom to Operate) analyses, and supporting the development of proprietary processes that enhance the company's competitive edge.

Beyond project management, Michael is deeply involved in process transfer activities, ensuring seamless scale-up from laboratory to manufacturing while maintaining quality and compliance. His commitment to HSE standards and regulatory adherence underscores his dedication to safe and sustainable pharmaceutical development. With his comprehensive skill set in Forschung und Entwicklung, organic chemistry, and process innovation, Michael continues to drive Arevipharma’s mission to deliver high-quality APIs through cutting-edge chemical development and strategic business growth initiatives.